Follow
Lars Dyrskjøt
Lars Dyrskjøt
Other namesLars Dyrskjot, Lars Dyrskjøt Andersen
Professor of Molecular Medicine, Aarhus University
Verified email at clin.au.dk
Title
Cited by
Cited by
Year
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
J Bartkova, N Rezaei, M Liontos, P Karakaidos, D Kletsas, N Issaeva, ...
Nature 444 (7119), 633-637, 2006
22772006
A consensus molecular classification of muscle-invasive bladder cancer
A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ...
European urology 77 (4), 420-433, 2020
9252020
Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer
T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ...
JAMA oncology 5 (8), 1124-1131, 2019
6732019
Diagnostic and prognostic microRNAs in stage II colon cancer
T Schepeler, JT Reinert, MS Ostenfeld, LL Christensen, AN Silahtaroglu, ...
Cancer research 68 (15), 6416-6424, 2008
6222008
Identifying distinct classes of bladder carcinoma using microarrays
L Dyrskjøt, T Thykjaer, M Kruhøffer, JL Jensen, N Marcussen, ...
Nature genetics 33 (1), 90-96, 2003
5872003
Comprehensive transcriptional analysis of early-stage urothelial carcinoma
J Hedegaard, P Lamy, I Nordentoft, F Algaba, S Høyer, BP Ulhøi, S Vang, ...
Cancer cell 30 (1), 27-42, 2016
5822016
A dual program for translation regulation in cellular proliferation and differentiation
H Gingold, D Tehler, NR Christoffersen, MM Nielsen, F Asmar, ...
Cell 158 (6), 1281-1292, 2014
4892014
Gene Expression in the Urinary Bladder: A Common Carcinoma in Situ Gene Expression Signature Exists Disregarding Histopathological Classification
L Dyrskjøt, M Kruhøffer, T Thykjaer, N Marcussen, JL Jensen, K Møller, ...
Cancer research 64 (11), 4040-4048, 2004
4792004
Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro
L Dyrskjøt, MS Ostenfeld, JB Bramsen, AN Silahtaroglu, P Lamy, ...
Cancer research 69 (11), 4851-4860, 2009
4562009
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis
K Thorsen, KD Sørensen, AS Brems-Eskildsen, C Modin, M Gaustadnes, ...
Molecular & Cellular Proteomics 7 (7), 1214-1224, 2008
4512008
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
ED Wiklund, JB Bramsen, T Hulf, L Dyrskjøt, R Ramanathan, TB Hansen, ...
International journal of cancer 128 (6), 1327-1334, 2011
4362011
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma
E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ...
Journal of Clinical Oncology 37 (18), 1547-1557, 2019
3952019
Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue
J Hedegaard, K Thorsen, MK Lund, AMK Hein, SJ Hamilton-Dutoit, ...
PloS one 9 (5), e98187, 2014
3662014
Comparative analysis of discrete exosome fractions obtained by differential centrifugation
DK Jeppesen, ML Hvam, B Primdahl-Bengtson, AT Boysen, B Whitehead, ...
Journal of extracellular vesicles 3 (1), 25011, 2014
3532014
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome
Y Allory, W Beukers, A Sagrera, M Flández, M Marqués, M Márquez, ...
European urology 65 (2), 360-366, 2014
3002014
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties
MS Ostenfeld, DK Jeppesen, JR Laurberg, AT Boysen, JB Bramsen, ...
Cancer research 74 (20), 5758-5771, 2014
2982014
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
2682020
Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification
AN Silahtaroglu, D Nolting, L Dyrskjøt, E Berezikov, M Møller, ...
Nature protocols 2 (10), 2520-2528, 2007
2622007
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
AB Als, L Dyrskjøt, H von der Maase, K Koed, F Mansilla, HE Toldbod, ...
Clinical Cancer Research 13 (15), 4407-4414, 2007
2512007
Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers
T Reinert, C Modin, FM Castano, P Lamy, TK Wojdacz, LL Hansen, C Wiuf, ...
Clinical cancer research 17 (17), 5582-5592, 2011
2282011
The system can't perform the operation now. Try again later.
Articles 1–20